Intech Biopharm Corporation (TPEX: 6461)

Intech Biopharm Revenue

Intech Biopharm had revenue of 5.21M TWD in the quarter ending June 30, 2024, a decrease of -47.39%. This brings the company's revenue in the last twelve months to 32.28M, up 58.76% year-over-year. In the year 2023, Intech Biopharm had annual revenue of 25.85M with 9.30% growth.

• Revenue (ttm): 32.28M
• Revenue Growth: +58.76%
• P/S Ratio: 117.44
• Revenue / Employee: 393.63K
• Employees: 82
• Market Cap: 3.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	25.85M	2.20M	9.30%
Dec 31, 2022	23.65M	-15.25M	-39.21%
Dec 31, 2021	38.90M	17.79M	84.30%
Dec 31, 2020	21.11M	4.42M	26.50%
Dec 31, 2019	16.68M	-550.00K	-3.19%